Results Snapshot
Figures in Rs cr
Standalone Half Yearly Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2024 is 12.04% vs 14.27% in Sep 2023
Standalone Net Profit
Growth in half year ended Sep 2024 is -35.45% vs 25.62% in Sep 2023
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2024 is 22.25% vs 20.77% in Sep 2023
Interest
Growth in half year ended Sep 2024 is 88.24% vs -10.53% in Sep 2023
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2024 has improved from Sep 2023
Compare Half Yearly Results Of RPG LifeScience. With
Figures in Rs cr
Standalone Half Yearly Results
Change(INR)
Change(%)
Net Sales
337.63
4,933.00
-4,595.37
-93.16%
Other Operating Income
0.00
0.00
0.00
Total Operating income
337.63
4,933.00
-4,595.37
-93.16%
Raw Material Cost
53.18
386.36
-333.18
-86.24%
Purchase of Finished goods
51.22
988.27
-937.05
-94.82%
(Increase) / Decrease In Stocks
4.78
15.23
-10.45
-68.61%
Employee Cost
65.83
1,047.96
-982.13
-93.72%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
77.62
1,170.95
-1,093.33
-93.37%
Total Expenditure (Excl Depreciation)
252.63
3,608.77
-3,356.14
-93.00%
Operating Profit (PBDIT) excl Other Income
85.00
1,324.23
-1,239.23
-93.58%
Other Income
4.31
200.59
-196.28
-97.85%
Operating Profit (PBDIT)
89.31
1,524.82
-1,435.51
-94.14%
Interest
0.32
8.18
-7.86
-96.09%
Exceptional Items
-27.30
61.23
-88.53
-144.59%
Gross Profit (PBDT)
61.69
1,516.64
-1,454.95
-95.93%
Depreciation
10.60
168.82
-158.22
-93.72%
Profit Before Tax
51.09
1,347.82
-1,296.73
-96.21%
Tax
20.13
261.13
-241.00
-92.29%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
30.96
1,086.69
-1,055.73
-97.15%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
61.23
-61.23
-100.00%
Net Profit
30.96
1,147.92
-1,116.96
-97.30%
Equity Capital
13.23
40.06
-26.83
-66.97%
Face Value
8.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
18.72
28.66
-9.94
-34.68%
Diluted Earnings per share
18.72
28.61
-9.89
-34.57%
Operating Profit Margin (Excl OI)
25.18%
26.84%
0.00
-1.66%
Gross Profit Margin
18.27%
30.74%
0.00
-12.47%
PAT Margin
9.17%
22.03%
0.00
-12.86%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 337.63 Cr
in Sep 2024Figures in Rs Cr
Growth in half year ended Sep 2024 is 12.04% vs 14.27% in Sep 2023
Half Yearly - Standalone Net Profit
Standalone Net Profit 30.96 Cr
in Sep 2024Figures in Rs Cr
Growth in half year ended Sep 2024 is -35.45% vs 25.62% in Sep 2023
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 85.00 Cr
in Sep 2024Figures in Rs Cr
Growth in half year ended Sep 2024 is 22.25% vs 20.77% in Sep 2023
Half Yearly - Interest
Interest 0.32 Cr
in Sep 2024Figures in Rs Cr
Growth in half year ended Sep 2024 is 88.24% vs -10.53% in Sep 2023
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.18%
in Sep 2024Figures in Rs %
Growth in half year ended Sep 2024 has improved from Sep 2023